1. Home
  2. CINGW vs JLS Comparison

CINGW vs JLS Comparison

Compare CINGW & JLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CINGW
  • JLS
  • Stock Information
  • Founded
  • CINGW N/A
  • JLS 2009
  • Country
  • CINGW United States
  • JLS United States
  • Employees
  • CINGW 13
  • JLS N/A
  • Industry
  • CINGW Biotechnology: Pharmaceutical Preparations
  • JLS Investment Managers
  • Sector
  • CINGW Health Care
  • JLS Finance
  • Exchange
  • CINGW Nasdaq
  • JLS Nasdaq
  • Market Cap
  • CINGW N/A
  • JLS 102.7M
  • IPO Year
  • CINGW 2021
  • JLS N/A
  • Fundamental
  • Price
  • CINGW $0.06
  • JLS $18.92
  • Analyst Decision
  • CINGW
  • JLS
  • Analyst Count
  • CINGW 0
  • JLS 0
  • Target Price
  • CINGW N/A
  • JLS N/A
  • AVG Volume (30 Days)
  • CINGW N/A
  • JLS 26.6K
  • Earning Date
  • CINGW N/A
  • JLS 01-01-0001
  • Dividend Yield
  • CINGW N/A
  • JLS 9.33%
  • EPS Growth
  • CINGW N/A
  • JLS N/A
  • EPS
  • CINGW N/A
  • JLS N/A
  • Revenue
  • CINGW N/A
  • JLS N/A
  • Revenue This Year
  • CINGW N/A
  • JLS N/A
  • Revenue Next Year
  • CINGW N/A
  • JLS N/A
  • P/E Ratio
  • CINGW N/A
  • JLS N/A
  • Revenue Growth
  • CINGW N/A
  • JLS N/A
  • 52 Week Low
  • CINGW N/A
  • JLS $15.48
  • 52 Week High
  • CINGW N/A
  • JLS $17.97
  • Technical
  • Relative Strength Index (RSI)
  • CINGW N/A
  • JLS 68.02
  • Support Level
  • CINGW N/A
  • JLS $18.56
  • Resistance Level
  • CINGW N/A
  • JLS $19.05
  • Average True Range (ATR)
  • CINGW 0.00
  • JLS 0.13
  • MACD
  • CINGW 0.00
  • JLS 0.03
  • Stochastic Oscillator
  • CINGW 0.00
  • JLS 76.36

About CINGW Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

About JLS Nuveen Mortgage and Income Fund

Nuveen Mortgage And Income Fund is a diversified, closed-end management investment company. The Fund invests at least fifty percent of its Managed Assets in MBS, including residential MBS and commercial MBS, and up to fifty percent in non-mortgage related ABS. Its investment objective to generate high current income through opportunistic investments in securitized credit.

Share on Social Networks: